iRadimed Corporation (IRMD) News

iRadimed Corporation (IRMD): $29.33

-1.21 (-3.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter IRMD News Items

IRMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IRMD News Highlights

  • IRMD's 30 day story count now stands at 2.
  • Over the past 3 days, the trend for IRMD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest IRMD News From Around the Web

Below are the latest news stories about IRADIMED CORP that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

There's Been No Shortage Of Growth Recently For IRadimed's (NASDAQ:IRMD) Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Yahoo | August 13, 2022

3 Healthcare Stocks With High Profit Margins

If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.

Yahoo | August 10, 2022

Is Now The Time To Put IRadimed (NASDAQ:IRMD) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Yahoo | July 30, 2022

IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 12.50% and 0.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 29, 2022

IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three and six months ended June 30, 2022. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a n

Yahoo | July 29, 2022

UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. IRADIMED has scheduled a conference call to discuss this announcement beginning at 11:00 a.m. Eastern Time today, July 29, 202

Yahoo | July 28, 2022

IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in listening to the conference call may do so by registering here https://register.vevent.com/register/

Yahoo | July 22, 2022

Could The Market Be Wrong About IRadimed Corporation (NASDAQ:IRMD) Given Its Attractive Financial Prospects?

It is hard to get excited after looking at IRadimed's (NASDAQ:IRMD) recent performance, when its stock has declined 26...

Yahoo | June 30, 2022

Investors in IRadimed (NASDAQ:IRMD) have made a massive return of 313% over the past five years

IRadimed Corporation ( NASDAQ:IRMD ) shareholders might understandably be very concerned that the share price has...

Yahoo | May 30, 2022

IRADIMED Names John F. Glenn Chief Financial Officer

WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and finance, including business planning and modeling, organizational resource planning, investor and analyst relations, and required reporting and related filings with the SEC. Mr. Glenn, 60, is a Financial Executive with o

Yahoo | May 26, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4593 seconds.